Loading...
Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin‐angiotensin‐aldosterone system
The effect of recombinant erythropoietin (rhEPO) on renal and systemic hemodynamics was evaluated in a randomized double‐blinded, cross‐over study. Sixteen healthy subjects were tested with placebo, or low‐dose rhEPO for 2 weeks, or high‐dose rhEPO for 3 days. Subjects refrained from excessive salt...
Na minha lista:
| Udgivet i: | Physiol Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5835499/ https://ncbi.nlm.nih.gov/pubmed/29504258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13573 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|